PRESS-RELEASE ·Filed Jun 16, 2026
Press release · Leadership
Actionable Insight • Neutral
Monitor for any strategic shifts or operational updates under new CEO, but no immediate stock-moving catalyst. The transition appears orderly with the former CEO remaining Chairman.
Latest settled — T+20d
NUWE ▼ -37.78% at T+20d
NEUTRAL call -37.78% · α vs SPY -37.83% · entry $0.1350 → $0.0840
Latest observation: T+50 +77.06% FF3 residual α
T+1d
+2.22%
call +2.22% · α +3.47%
$0.1380
settled 4mo ago
T+5d
-34.07%
call -34.07% · α -31.80%
$0.0890
settled 4mo ago
T+20d
-37.78%
call -37.78% · α -37.83%
$0.0840
settled 3mo ago
T+60d
Pending
due 7w ago
Price Chart
Loading chart...
Executive Summary
Nuwellis announces Mike McCormick as new CEO effective June 30, 2026, with outgoing CEO John Erb remaining Chairman. This is a routine leadership transition at a micro-cap medical device company with no accompanying financial or operational updates.
Key Facts
- Mike McCormick appointed CEO effective June 30, 2026
- John Erb transitions from CEO to Chairman of the Board
- McCormick previously served as Nuwellis Board Member from June 2023 through January 2026
- No financial guidance, revenue, or operational metrics disclosed
Financial Impact
No financial impact disclosed; routine leadership change
Risk Factors
- Execution risk under new leadership at a micro-cap company with limited resources
- Potential for further dilution or cash burn given $2M market cap and no disclosed financial improvement
Market Snapshot
Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
0% bullish (6 analysts)
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3312567 |
23 reports for NUWE
100% Hit rate @ T+20 Went positive at some point 13 of 13 best @ T+60▲ +96.33%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $0.3221 | awaiting T+20 | — | $3.07 (+851.69%) |
Sep 18, 2026 5w ago | SC 13G/A | $0.8700 $0.5600 | ▼ −35.63% | ▼ −34.72% | $3.07 (+252.34%) |
Sep 17, 2026 5w ago | Press Release | $1.09 $0.5532 | ▲ +49.25% | ▲ +50.45% | $3.07 (−181.23%) |
Aug 27, 2026 8w ago | EFFECT | $0.9900 $0.7915 | ▲ +20.05% | ▲ +19.95% | $3.07 (−209.64%) |
Aug 25, 2026 8w ago | 8-K | $1.01 $0.8700 | ▼ −13.86% | ▼ −15.06% | $3.07 (+203.50%) |
Aug 13, 2026 10w ago | Press Release | $1.30 $0.7740 | ▲ +40.46% | ▲ +38.71% | $3.07 (−135.80%) |
Aug 3, 2026 12w ago | 424B5 | $14.49 $7.13 | ▲ +50.78% | ▲ +52.01% | $3.07 (+78.84%) |
Jul 31, 2026 12w ago | Press Release | $1.74 $0.8889 | ▲ +48.91% | ▲ +51.90% | $3.07 (−76.17%) |
Jun 16, 2026 18w ago | Press Release | $0.1350 $0.0840 | ▼ −37.78% | ▼ −37.83% | $3.07 (+2170.67%) |
Jun 10, 2026 19w ago | 8-K | $0.1520 $0.0869 | ▲ +42.86% | ▲ +46.93% | $3.07 (−1916.71%) |
Showing 10 of 23
US Market Status
Market Closed — Opens in 7h 2m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers